RCKT ROCKET PHARMACEUTICALS, INC.
Nasdaq · SEC CIK 1281895 · EDGAR
- Bought, last 12 months
- $34.4K 1 purchases by 1 insiders
- Sold, last 12 months
- $978.5K 26 sales by 6 insiders
- Filings on record
- 224 since 2021-08-31, latest 2026-09-15 20:27
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Wilson Martin | GC | — | $334.6K |
| Shah Gaurav | CEO, Dir | — | $285.6K |
| Militello John | See Remarks | — | $138.3K |
| Stevens Christopher James | COO | — | $128.3K |
| Chaudhuri Sarbani | See Remarks | — | $84.2K |
| Bjork Elisabeth | Dir | $34.4K | — |
| Schwartz Jonathan David | See Remarks | — | $7,584 |
| Fong Peter | Dir | — | — |
| Rizvi Syed Ali-aamir | Chief Medical Off | — | — |
| Malik Fady Ibraham | Dir | — | — |
Transactions 188
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 20:27 | 2026-09-11 | RCKT | Wilson Martin | GC | S - Sale | $3.40 | -75.4K | 598.5K | -11% | -$256.5K | |
| 2026-08-20 17:30 | 2026-08-18 | RCKT | Wilson Martin | GC | S - Sale | $3.38 | -631 | 673.9K | -0.1% | -$2,133 | |
| 2026-08-20 17:25 | 2026-08-18 | RCKT | Shah Gaurav | CEO | S - Sale | $3.38 | -2,293 | 1.06M | -0.2% | -$7,753 | |
| 2026-08-17 17:52 | 2026-08-13 | RCKT | Shah Gaurav | CEO | S - Sale | $3.38 | -2,837 | 1.06M | -0.3% | -$9,592 | |
| 2026-08-17 17:50 | 2026-08-13 | RCKT | Wilson Martin | GC | S - Sale | $3.38 | -3,493 | 674.5K | -0.5% | -$11.8K | |
| 2026-08-13 16:15 | 2026-08-11 | RCKT | Stevens Christopher James | COO | S - Sale | $3.50 | -36.7K | 505.8K | -7% | -$128.3K | |
| 2026-08-13 16:15 | 2026-08-11 | RCKT | Chaudhuri Sarbani | See Remarks | S - Sale | $3.50 | -4,701 | 262.8K | -2% | -$16.4K | |
| D | 2026-08-05 20:49 | 2026-08-03 | RCKT | Stevens Christopher James | COO | A - Grant | $0.00 | +73.3K | 542.4K | +16% | $0 |
| 2026-08-05 20:45 | 2026-08-03 | RCKT | SOUTHWELL DAVID P | Dir | J - Other | $0.00 | +150.0K | 204.5K | +275% | $0 | |
| D | 2026-07-06 20:00 | 2026-06-18 | RCKT | WONG RODERICK | Dir, 10% | A - Grant | $0.00 | +27.8K | 75.5K | +58% | $0 |
| D | 2026-07-06 20:00 | 2026-06-18 | RCKT | Fong Peter | Dir | A - Grant | $0.00 | +22.9K | 76.2K | +43% | $0 |
| D | 2026-07-06 19:59 | 2026-06-18 | RCKT | Dolsten Mikael | Dir | A - Grant | $0.00 | +22.9K | 67.1K | +52% | $0 |
| D | 2026-07-06 19:59 | 2026-06-18 | RCKT | Malik Fady Ibraham | Dir | A - Grant | $0.00 | +22.9K | 52.9K | +76% | $0 |
| D | 2026-07-06 19:59 | 2026-06-18 | RCKT | SOUTHWELL DAVID P | Dir | A - Grant | $0.00 | +22.9K | 54.5K | +72% | $0 |
| D | 2026-07-06 19:59 | 2026-06-18 | RCKT | BOESS CARSTEN | Dir | A - Grant | $0.00 | +22.9K | 52.9K | +76% | $0 |
| D | 2026-05-26 19:47 | 2026-05-21 | RCKT | Shah Gaurav | CEO | M - OptEx | $1.69 | +76.5K | 1.12M | +7% | +$129.3K |
| D | 2026-05-26 19:47 | 2026-05-21 | RCKT | Shah Gaurav | CEO | S - Sale+OE | $3.09 | -55.7K | 1.06M | -5% | -$171.8K |
| 2026-05-21 16:06 | 2026-05-19 | RCKT | Shah Gaurav | CEO | S - Sale | $3.01 | -2,409 | 1.04M | -0.2% | -$7,261 | |
| 2026-05-21 16:06 | 2026-05-19 | RCKT | Wilson Martin | GC | S - Sale | $3.01 | -662 | 678.0K | -0.1% | -$1,995 | |
| 2026-05-21 16:06 | 2026-05-19 | RCKT | Militello John | See Remarks | S - Sale | $3.01 | -384 | 89.8K | -0.4% | -$1,157 | |
| 2026-05-14 16:22 | 2026-05-13 | RCKT | Wilson Martin | GC | S - Sale | $3.61 | -3,361 | 678.6K | -0.5% | -$12.1K | |
| 2026-05-14 16:19 | 2026-05-13 | RCKT | Shah Gaurav | CEO | S - Sale | $3.61 | -2,728 | 1.04M | -0.3% | -$9,837 | |
| 2026-05-14 16:16 | 2026-05-13 | RCKT | Militello John | See Remarks | S - Sale | $3.61 | -855 | 90.2K | -0.9% | -$3,083 | |
| 2026-05-11 19:48 | 2026-05-07 | RCKT | Chaudhuri Sarbani | See Remarks | S - Sale | $3.84 | -17.6K | 267.5K | -6% | -$67.7K | |
| 2026-02-20 | 2026-02-18 | RCKT | Shah Gaurav | CEO | S - Sale | $3.34 | -5,990 | 1.05M | -0.6% | -$20.0K | |
| 2026-02-20 | 2026-02-18 | RCKT | Militello John | See Remarks | S - Sale | $3.34 | -1,157 | 91.0K | -1% | -$3,864 | |
| 2026-02-20 | 2026-02-18 | RCKT | Wilson Martin | GC | S - Sale | $3.34 | -1,376 | 682.0K | -0.2% | -$4,596 | |
| 2026-02-18 | 2026-02-13 | RCKT | Shah Gaurav | CEO | S - Sale | $3.31 | -12.3K | 1.05M | -1% | -$40.6K | |
| 2026-02-18 | 2026-02-13 | RCKT | Militello John | See Remarks | S - Sale | $3.31 | -3,726 | 92.2K | -4% | -$12.3K | |
| 2026-02-18 | 2026-02-13 | RCKT | Wilson Martin | GC | S - Sale | $3.31 | -12.3K | 683.4K | -2% | -$40.6K | |
| D | 2026-02-13 | 2026-02-11 | RCKT | Chaudhuri Sarbani | See Remarks | A - Grant | $0.00 | +125.9K | 285.2K | +79% | $0 |
| D | 2026-02-13 | 2026-02-11 | RCKT | Militello John | See Remarks | A - Grant | $0.00 | +30.0K | 95.9K | +45% | $0 |
| D | 2026-02-13 | 2026-02-11 | RCKT | Stevens Christopher James | COO | A - Grant | $0.00 | +62.0K | 469.1K | +15% | $0 |
| D | 2026-02-13 | 2026-02-11 | RCKT | Rizvi Syed Ali-aamir | Chief Medical Off | A - Grant | $0.00 | +62.0K | 407.9K | +18% | $0 |
| D | 2026-02-13 | 2026-02-11 | RCKT | Wilson Martin | GC | A - Grant | $0.00 | +311.8K | 695.6K | +81% | $0 |
| D | 2026-02-13 | 2026-02-11 | RCKT | Shah Gaurav | CEO | A - Grant | $0.00 | +286.0K | 1.06M | +37% | $0 |
| 2026-01-06 | 2026-01-02 | RCKT | Bjork Elisabeth | Dir | P - Purchase | $3.44 | +10.0K | 50.0K | +25% | +$34.4K | |
| 2025-11-20 | 2025-11-18 | RCKT | Wilson Martin | GC | S - Sale | $2.98 | -1,646 | 383.8K | -0.4% | -$4,905 | |
| 2025-11-20 | 2025-11-18 | RCKT | Shah Gaurav | CEO, Dir | S - Sale | $2.98 | -6,276 | 778.3K | -0.8% | -$18.7K | |
| 2025-11-20 | 2025-11-18 | RCKT | Militello John | See Remarks | S - Sale | $2.98 | -1,086 | 65.9K | -2% | -$3,236 | |
| 2025-11-20 | 2025-11-18 | RCKT | Schwartz Jonathan David | See Remarks | S - Sale | $2.98 | -2,545 | 299.1K | -0.8% | -$7,584 | |
| 2025-11-10 | 2025-11-03 | RCKT | Wilson Martin | GC | A - Grant | $0.00 | +100.0K | 385.5K | +35% | $0 | |
| M | 2025-10-16 | 2025-10-14 | RCKT | Militello John | See Remarks | S - Sale | $3.96 | -28.9K | 70.6K | -29% | -$114.6K |
| DM | 2025-10-08 | 2025-10-06 | RCKT | Rizvi Syed Ali-aamir | Chief Medical Off | A - Grant | $0.00 | +345.9K | 283.0K | New | $0 |
| M | 2025-10-03 | 2025-09-24 | RCKT | Fong Peter | Dir | A - Grant | $0.00 | +53.3K | 53.3K | New | $0 |
| DMI | 2025-09-23 | 2025-09-19 | RCKT | RTW INVESTMENTS, LP | Dir, 10%, See remarks | J - Other | $3.11 | -1.10M | 18.19M | -6% | -$3.42M |
| DMI | 2025-09-23 | 2025-09-19 | RCKT | RTW INVESTMENTS, LP | Dir, 10%, See remarks | X - OptEx | $38.06 | +1.10M | 18.25M | +6% | +$41.86M |
| 2025-09-09 | 2025-09-08 | RCKT | Wilson Martin | GC | A - Grant | $0.00 | +150.0K | 285.5K | +111% | $0 | |
| 2025-09-09 | 2025-09-08 | RCKT | Schwartz Jonathan David | See Remarks | A - Grant | $0.00 | +80.0K | 301.6K | +36% | $0 | |
| 2025-09-09 | 2025-09-08 | RCKT | Militello John | See Remarks | A - Grant | $0.00 | +40.0K | 95.9K | +72% | $0 | |
| 2025-08-27 | 2025-08-27 | RCKT | Bjork Elisabeth | Dir | P - Purchase | $3.41 | +10.0K | 40.0K | +33% | +$34.1K | |
| 2025-08-20 | 2025-08-18 | RCKT | Shah Gaurav | CEO, Dir | F - Tax | $3.05 | -2,234 | 784.6K | -0.3% | -$6,814 | |
| M | 2025-08-20 | 2025-08-18+ | RCKT | Militello John | See Remarks | S - Sale | $3.05 | -1,060 | 55.9K | -2% | -$3,229 |
| M | 2025-08-20 | 2025-08-18+ | RCKT | Wilson Martin | GC | S - Sale | $3.04 | -1,592 | 136.1K | -1% | -$4,846 |
| M | 2025-08-20 | 2025-08-18+ | RCKT | Schwartz Jonathan David | See Remarks | S - Sale | $3.05 | -2,485 | 221.6K | -1% | -$7,573 |
| 2025-08-18 | 2025-08-14 | RCKT | Schwartz Jonathan David | See Remarks | S - Sale | $3.02 | -11.2K | 224.1K | -5% | -$33.7K | |
| 2025-08-18 | 2025-08-14 | RCKT | Militello John | See Remarks | S - Sale | $3.02 | -7,043 | 57.0K | -11% | -$21.3K | |
| 2025-08-18 | 2025-08-14 | RCKT | Wilson Martin | GC | S - Sale | $3.02 | -12.1K | 137.1K | -8% | -$36.6K | |
| D | 2025-08-06 | 2025-08-04 | RCKT | Stevens Christopher James | COO | A - Grant | $0.00 | +407.2K | 407.2K | New | $0 |
| 2025-07-18 | 2025-06-18 | RCKT | BOESS CARSTEN | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 | |
| M | 2025-07-18 | 2025-06-18 | RCKT | WONG RODERICK | Dir, 10% | A - Grant | $0.00 | +47.7K | 47.7K | New | $0 |
| M | 2025-07-18 | 2025-06-18 | RCKT | GRANADILLO PEDRO P | Dir | A - Grant | $0.00 | +54.7K | 54.7K | New | $0 |
| 2025-07-18 | 2025-06-18 | RCKT | Bjork Elisabeth | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 | |
| 2025-07-18 | 2025-06-18 | RCKT | Dolsten Mikael | Dir | A - Grant | $0.00 | +30.0K | 44.2K | +211% | $0 | |
| MI | 2025-07-18 | 2025-06-18 | RCKT | Makker Gotham | Dir | A - Grant | $0.00 | +49.4K | 395.9K | +14% | $0 |
| 2025-07-18 | 2025-06-18 | RCKT | Pratumsuwan Piratip | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 | |
| 2025-07-18 | 2025-06-18 | RCKT | SOUTHWELL DAVID P | Dir | A - Grant | $0.00 | +30.0K | 31.7K | +1,807% | $0 | |
| 2025-07-18 | 2025-06-18 | RCKT | Malik Fady Ibraham | Dir | A - Grant | $0.00 | +30.0K | 30.0K | New | $0 | |
| 2025-07-08 | 2025-07-03 | RCKT | Ondrey Aaron | CFO | S - Sale | $2.88 | -1,477 | 128.2K | -1% | -$4,254 | |
| 2025-05-22 | 2025-05-20 | RCKT | Patel Kinnari | See Remarks | S - Sale | $6.45 | -767 | 441.9K | -0.2% | -$4,947 | |
| 2025-05-22 | 2025-05-20 | RCKT | Wilson Martin | GC | S - Sale | $6.45 | -587 | 149.2K | -0.4% | -$3,786 | |
| 2025-05-22 | 2025-05-20 | RCKT | Schwartz Jonathan David | See Remarks | S - Sale | $6.45 | -801 | 235.3K | -0.3% | -$5,166 | |
| 2025-05-22 | 2025-05-20 | RCKT | Militello John | See Remarks | S - Sale | $6.45 | -357 | 64.0K | -0.6% | -$2,303 | |
| 2025-05-22 | 2025-05-20 | RCKT | Shah Gaurav | CEO, Dir | S - Sale | $6.45 | -2,253 | 786.8K | -0.3% | -$14.5K | |
| 2025-05-20 | 2025-05-16 | RCKT | Wilson Martin | GC | S - Sale | $6.53 | -946 | 149.8K | -0.6% | -$6,177 | |
| 2025-05-20 | 2025-05-16 | RCKT | Patel Kinnari | See Remarks | S - Sale | $6.53 | -1,409 | 442.7K | -0.3% | -$9,201 | |
| 2025-05-20 | 2025-05-16 | RCKT | Militello John | See Remarks | S - Sale | $6.53 | -655 | 64.4K | -1% | -$4,277 | |
| 2025-05-20 | 2025-05-16 | RCKT | Shah Gaurav | CEO, Dir | S - Sale | $6.53 | -3,621 | 789.1K | -0.5% | -$23.6K | |
| 2025-05-20 | 2025-05-16 | RCKT | Schwartz Jonathan David | See Remarks | S - Sale | $6.53 | -1,582 | 236.1K | -0.7% | -$10.3K | |
| 2025-04-24 | 2025-04-22 | RCKT | Militello John | See Remarks | S - Sale | $7.16 | -718 | 65.0K | -1% | -$5,141 | |
| 2025-04-24 | 2025-03-05 | RCKT | Dolsten Mikael | Dir | J - Other | $0.00 | +14.2K | 14.2K | New | $0 | |
| 2025-04-14 | 2025-04-10 | RCKT | Shah Gaurav | CEO, Dir | P - Purchase | $5.08 | +20.0K | 792.7K | +3% | +$101.6K | |
| I | 2025-04-10 | 2025-04-09 | RCKT | Patel Kinnari | See Remarks | P - Purchase | $4.70 | +21.1K | 26.8K | +372% | +$99.2K |
| 2025-04-08 | 2025-04-04 | RCKT | Ondrey Aaron | CFO | S - Sale | $5.29 | -7,489 | 129.7K | -5% | -$39.6K | |
| M | 2025-02-27 | 2024-05-17+ | RCKT | Schwartz Jonathan David | See Remarks | S - Sale | $14.84 | -15.1K | 166.9K | -8% | -$224.0K |
| 2025-02-25 | 2025-02-21 | RCKT | Militello John | See Remarks | S - Sale | $10.58 | -2,737 | 65.8K | -4% | -$29.0K | |
| 2025-02-25 | 2025-02-21 | RCKT | Shah Gaurav | CEO, Dir | S - Sale | $10.58 | -16.3K | 772.7K | -2% | -$172.5K | |
| 2025-02-25 | 2025-02-21 | RCKT | Patel Kinnari | See Remarks | S - Sale | $10.58 | -6,078 | 444.1K | -1% | -$64.3K | |
| 2025-02-25 | 2025-02-21 | RCKT | Wilson Martin | GC | S - Sale | $10.58 | -3,222 | 150.7K | -2% | -$34.1K | |
| D | 2025-02-13 | 2025-02-11 | RCKT | Ondrey Aaron | CFO | A - Grant | $0.00 | +90.4K | 137.1K | +193% | $0 |
| D | 2025-02-13 | 2025-02-11 | RCKT | Wilson Martin | GC | A - Grant | $0.00 | +90.4K | 153.9K | +142% | $0 |
| D | 2025-02-13 | 2025-02-11 | RCKT | Shah Gaurav | CEO, Dir | A - Grant | $0.00 | +81.7K | 789.0K | +12% | $0 |
| D | 2025-02-13 | 2025-02-11 | RCKT | Patel Kinnari | See Remarks | A - Grant | $0.00 | +57.8K | 450.2K | +15% | $0 |
| D | 2025-02-13 | 2025-02-11 | RCKT | Militello John | See Remarks | A - Grant | $0.00 | +20.1K | 68.5K | +41% | $0 |
| D | 2025-02-13 | 2025-02-11 | RCKT | Schwartz Jonathan David | See Remarks | A - Grant | $0.00 | +80.3K | 252.7K | +47% | $0 |
| 2025-01-27 | 2025-01-23 | RCKT | Militello John | See Remarks | S - Sale | $10.38 | -896 | 48.4K | -2% | -$9,300 | |
| 2024-11-25 | 2024-11-21 | RCKT | Shah Gaurav | CEO, Dir | S - Sale | $13.05 | -11.1K | 707.3K | -2% | -$144.7K | |
| 2024-11-25 | 2024-11-21 | RCKT | Militello John | See Remarks | S - Sale | $13.05 | -1,224 | 49.3K | -2% | -$16.0K | |
| 2024-11-25 | 2024-11-21 | RCKT | Patel Kinnari | See Remarks | S - Sale | $13.05 | -4,588 | 392.4K | -1% | -$59.9K | |
| 2024-11-25 | 2024-11-21 | RCKT | Wilson Martin | GC | S - Sale | $13.05 | -1,175 | 63.6K | -2% | -$15.3K |
Purchase Sale Sale after option exercise All abbreviations